United States AI-Powered Imaging Diagnostics Market Growing at 33.24% CAGR 2025-2030; North America Holds 38.79% Global Share

Global AI-powered Imaging Diagnostics Market size reached US$ 1.61 billion in 2024 and is expected to reach US$ 9.73 billion by 2033, growing at a CAGR of 22.3% during the forecast period 2025-2033.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/ai-powered-imaging-diagnostics-market?pratik

The AI-powered imaging diagnostics market is growing due to rising demand for faster, more accurate disease detection, increasing adoption of AI in hospitals, and the need to reduce diagnostic errors. Advancements in deep learning, expanding healthcare digitalization, and growing chronic disease cases further accelerate market expansion.

United States industry development
✅ The United States AI-powered Imaging Diagnostics Market size was approximately USD 696.94 million in 2025. It is projected to grow at a CAGR of 33.24% from 2025 to 2030.

✅ November 2025: Zebra Medical Vision launched a new AI-powered imaging diagnostic platform for radiology offering automated detection of critical conditions, integrating with existing hospital PACS systems.

✅ October 2025: Aidoc raised $15 million in venture funding for their AI solution targeting emergency imaging focused on stroke and pulmonary embolism detection to improve workflow efficiency.

✅ September 2025: Tempus AI received FDA 510(k) clearance for its Tempus Pixel platform, an AI-powered cardiac MR imaging tool for detecting fibrosis, inflammation, and edema on scanners without native support for T1 and T2 maps.

✅ September 2025: GE Healthcare announced intent to acquire icometrix, a firm specializing in AI-powered brain MRI analysis, signaling strategic expansion in AI diagnostics.

✅ August 2025: Tempus AI launched an upgraded AI platform enhancing cardiac and oncological imaging with deep learning for accurate tissue characterization and early disease detection.

Global Industry development
✅ September 2025 (Japan): Japan released "Curia," a large multi-modal AI foundation model trained on over 150,000 cross-sectional imaging exams for advanced organ identification, hemorrhage detection, and tumor staging.

✅ June 2025 (Japan): Terumo signed a distribution agreement to market AutocathFFR, an AI-based FFR software as a medical device for coronary diagnostics, sales starting October 2025.

✅ March 2025 (Japan): AI Medical Service showcased an approved endoscopic AI for gastrointestinal lesion detection at Expo 2025 Osaka, advancing real-time diagnostic imaging.

✅ August 2025 (Japan): Toshiba Medical Systems released an AI-powered imaging platform optimizing tumor and cardiovascular anomaly detection for hospitals and clinics.

Recent Merges & acquisition
→ In November 2025, GE HealthCare agreed to acquire Intelerad, a medical imaging software and enterprise workflow provider, for $2.3 billion in cash to accelerate its cloud-first, AI-enabled imaging strategy across outpatient, hospital, and teleradiology settings.

→ In September 2025, GE HealthCare announced its intent to acquire icometrix, a company specializing in AI-powered brain MRI analysis, which aligns with GE's precision care strategy in neurology.

→ In October 2025, Aidoc, an AI imaging diagnostics company, secured $15 million in venture funding to improve AI solutions for emergency imaging related to stroke and pulmonary embolism detection, positioning for growth and potential strategic expansions.

Market Segmentation-

Segmentation by Solution:
→ Software Tools/Platform: This segment dominates with an estimated market share of about 58.7% in 2025. It includes advanced AI software that integrates with imaging systems to provide analytics, automated image interpretation, and workflow optimization, which are critical for improving diagnostic accuracy and efficiency.

→ Services: Services encompass implementation, maintenance, and training related to AI imaging solutions, supporting the uptake of technology but with a smaller market share.

→ Hardware: Comprises AI-enabled imaging devices and equipment, steadily growing due to technological advancements but remaining less dominant than software.

Segmentation by Image Acquisition Technology:
→ Computed Tomography (CT): Leading segment with about 30.14% market share in 2025, CT imaging benefits from AI enhancement in image reconstruction, reducing scan time, and improving diagnostic precision across multiple diseases.

→ Magnetic Resonance Imaging (MRI): Used for detailed imaging; AI integration improves image quality and diagnostic workflows.

→ X-Ray, Ultrasound, Molecular Imaging: These technologies hold smaller shares but are enhanced by AI for specific applications such as oncology and cardiovascular diagnostics.

Segmentation by Application:
→ Oncology: AI aids in early cancer detection and treatment planning, contributing a significant share.

→ Cardiovascular, Neurology, Lung, Breast, Liver, Oral Diagnostics: These sub-segments represent focused applications of AI to improve diagnosis and management of respective diseases.

→ Digital Pathology: An emerging application powered by AI for automated tissue analysis, growing rapidly within the diagnostics market.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=ai-powered-imaging-diagnostics-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

Regional insights:-
→ North America leads the AI-powered imaging diagnostics market with the largest market share of approximately 38.79%. This dominance is due to a strong healthcare infrastructure, early adoption of advanced imaging technologies, and the presence of major AI healthcare solution providers, especially in the U.S. where the market share is about 60.5% within North America.

→ Asia-Pacific is the second largest region with a market share of around 23.3%. It is also the fastest growing region due to increased healthcare digitization, a rising disease burden, and strong government support for AI in healthcare across countries like China, India, and Japan.

→ Other regions such as Europe, Latin America, and the Middle East & Africa contribute smaller portions but are also growing markets influenced by healthcare investments and AI adoption in medical imaging

Key Players
Deepc GmbH, Qure.ai Technologies Private Limited, DeepTek.ai, Inc, Koninklijke Philips N.V., Tempus AI, Inc., Rayscape, Infervision, AIKENIST, Rad AI, Brainomix Limited, and among others.

→ Koninklijke Philips N.V. is a major global player known for its advanced diagnostic imaging technologies integrated with AI, leading in market share due to a robust global presence and extensive AI diagnostic solutions. Philips benefits from strong healthcare infrastructure, capturing significant market share, especially in North America, which holds around 38.79% of the global market.

→ Qure.ai Technologies Private Limited is an innovative AI healthcare startup focusing on AI algorithms for radiology imaging, known for its rapid adoption and cost-effective AI-powered diagnostic tools, especially targeting emerging markets. It leverages early and precise disease detection capabilities, supporting growing healthcare digitization.

→ Tempus AI, Inc. specializes in data-driven AI clinical applications, integrating AI for diagnostic imaging with precision medicine approaches. It is recognized for advancing personalized diagnostics through AI, capturing a sizeable share of the market by partnering with healthcare systems and deploying AI-powered imaging platforms.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/ai-powered-imaging-diagnostics-market?pratik

Market Drivers:-
Increasing demand for accurate, rapid diagnosis with minimal errors.

Growing prevalence of chronic diseases requiring advanced imaging analysis.

Integration of AI with radiology and pathology for improved diagnostic efficiency.

Government initiatives supporting AI adoption in healthcare.

Advances in digital biomarkers for early disease detection.

Rising healthcare automation causing workflow optimization.

Expansion of cloud computing and big data aiding AI tool scalability.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.